TAK:NYSE
Takeda Pharmaceutical Co Ltd
$21.77
arrow_upward
+1.59%(+0.34) 1D
$22.09
arrow_upward
+1.47% (+0.32)bedtimeAfter hours
Closed: Nov 20, 4:00:04 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TAK...
Open
$21.82
High
$22.07
Low
$21.74
Mkt. cap
71.06B
Avg. vol.
3.15M
Volume
3.80M
Dividend
2.90%
Quarterly dividend
$0.16
Ex-dividend date
Mar 30, 2027
P/E ratio
332.01
52-wk high
$22.07
52-wk low
$14.09
EPS
$0.07
Beta
-0.01
Shares outstanding
3.20B
No. of employees
47K
Open
$21.82
High
$22.07
Low
$21.74
Mkt. cap
71.06B
Avg. vol.
3.15M
Volume
3.80M
Dividend
2.90%
Quarterly dividend
$0.16
Ex-dividend date
Mar 30, 2027
P/E ratio
332.01
52-wk high
$22.07
52-wk low
$14.09
EPS
$0.07
Beta
-0.01
Shares outstanding
3.20B
No. of employees
47K
News stories
From web sources and news partners
24/7 Wall St.
·
1 hour ago
Billionaire Ray Dalio's Bridgewater Keeps 16% of Its $23 Billion Stock Portfolio in S&P 500 Index Funds, Even After Cutting Them
Crypto Briefing
·
2 hours ago
Nasdaq slides deeper as Nvidia rout drags S&P 500 and Dow into correction
Traders Union
·
4 hours ago
Ryan Detrick: S&P 500 rose after seven-day losing streak in 16 out of 17 years since 1978
TradingView
·
4 hours ago
Yardeni Trims S&P 500 Year-End Forecast Again, Says Bear Market Is Unlikely
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the largest pharmaceutical company in Japan, third largest such company in Asia behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47K
FoundedJun 12, 1781
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitetakeda.com